Correction: Vaccine potential of the Neisseria meningitidis 2086 lipoprotein [Infection and Immunity, 72, 4, (2004) (2088-2100)] DOI: 10.1128/IAI.72.4.2088-2100.2004;Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein

Infection and Immunity

Volumn 72, Issue 4, 2004, Pages 2088-2100

  Fletcher, Leah D ^a   Bernfield, Liesel ^a   Barniak, Vicki ^a   Farley, John E ^a   Howell, Alan ^a   Knauf, Melissa ^a   Ooi, Peggy ^a   Smith, Robert P ^a   Weise, Paige ^a   Wetherell, Mike ^a   Xie, Xiaoling ^a   Zagursky, Robert ^a   Zhang, Ying ^a   Zlotnick, Gary W ^a  

^a WYETH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; LIPOPROTEIN; LP 2086; OUTER MEMBRANE PROTEIN; VACCINE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; CROSS REACTION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FRACTIONATION; GENETIC VARIABILITY; NEISSERIA; NEISSERIA GONORRHOEAE; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEOMICS; SCREENING; WESTERN BLOTTING;

EID: 12144290906     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00212-17     Document Type: Erratum

References (45)

1. Abdillahi, H., and J. T. Poolman. 1987. Whole cell ELISA for typing Neissería meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48:367-371.
2. Ashton, F. E., L. Mancino, A. J. Ryan, J. T. Poolman, H. Abdillahi, and W. D. Zollinger. 1991. Serotypes and subtypes of Neisseria meningitidis serogroup B strains associated with meningococcal disease in Canada, 1977-1989. Can. J. Microbiol. 37:613-617.
3. Bentley, A. T., and P. E. Klebba. 1988. Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface. J. Bacteriol. 170:1063-1068.
4. Bernfield, L., L. Fletcher, A. Howell, J. Farley, R. Zagursky, M. Knauf, and G. Zlotnick. 2002. Identification of a novel vaccine candidate for group B Neisseria meningitidis, p. 116. In D. A. Caugant and E. Wedege (ed.), Abstracts of the Thirteenth International Pathogenic Neisseria Conference. National Institute of Public Health, Oslo, Norway.
5. Bessler, W. G., and G. Jung. 1992. Synthetic lipopeptides as novel adjuvants. Res. Immunol. 143:548-553.
6. Bjune, G., E. A. Hiby, J. K. Grnnesby, and O. Arnesen. 1991. Effect of an outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
7. Comanducci, M., S. Bambini, B. Brunelli, J. Adu-Bobie, B. Aricò, B. Capecchi, M. M. Giuliani, V. Masignani, L. Santini, S. Savino, D. M. Granoff, D. A. Caugant, M. Pizza, R. Rappouli, and M. Mora. 2002. NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195:1445-1454.
8. Diermayer, M., K. Hedberg, F. Hoesley, M. Fischer, B. Perkins, M. Reeves, and D. Fleming. 1999. Epidemic serogroup B meningococcal disease in Oregon. The evolving epidemiology of the ET-5 strain. JAMA 281:1493-1497.
9. English, M., J. M. MacLennan, J. M. Bowen-Morris, J. Deeks, M. Boardman, K. Brown, S. Smith, J. Buttery, J. Clarke, S. Quataert, S. Lockhart, and E. R. Moxon. 2001. A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants. Vaccine 19:1232-1238.
10. Finne, J., D. Bitter-Suermann, C. Goridis, and U. Finne. 1987. An IgG monoclonal antibody to group B meningococci crossreacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138:4402-4407.
11. Fletcher, L., J. Farley, L. Bernfield, A. Howell, M. Knauf, P. Weise, X. Xie, and Y. Zhang. 2002. Characterization, cloning and expression of different subfamilies of the ORF 2086 gene from Neisseria meningitidis, p. 124. In D. A. Caugant and E. Wedege (ed.), Abstracts of the Thirteenth International Pathogenic Neisseria Conference. National Institute of Public Health, Oslo, Norway.
12. Granoff, D. M., G. R. Moe, M. M. Giuliani, J. Adu-Bobie, L. Santini, B. Brunelli, F. Piccinetti, P. Zuno-Mitchell, S. S. Lee, P. Neri, L. Bracci, L. Lozzi, and R. Rappuoli. 2001. A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis. J. Immunol. 167:6487-6496.
13. Green, B. A., J. E. Farley, T. Quinn-Dey, R. A. Delch, and G. W. Zlotnick. 1991. The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect. Immun. 59:3191-3198.
14. BAD promoter. J. Bacteriol. 177:4121-4130.
15. Hayrinen, J., H. Jennings, H. V. Raff, G. Rougon, N. Hanai, R. Gerardy-Schahn, and J. Finne. 1995. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1481-1490.
16. Higgins, D. G., and R. Sharp. 1989. Fast and sensitive multiple sequence alignments on a microcomputer. Comput. Appl. Biosci. 5:151-153.
17. Jòdar, L., I. M. Feavers, D. Salisbury, and D. M. Granoff. 2002. Development of vaccines against meningococcal disease. Lancet 359:1499-1508.
18. Kellogg, D. S., W. L. Peacock, W. E. Deacon, L. Brown, and C. I. Pirkle. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J. Bacteriol. 85:1274-1279.
19. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
20. Lex, A., K. H. Wiesmuller, G. Jung, and W. G. Bessler. 1986. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant. J. Immunol. 137:2676-2681.
21. MacLennan, J. M., F. Shackley, P. T. Heath, J. J. Deeks, C. Flamank, M. Herbert, H. Griffiths, E. Hatzmann, C. Goilav, and E. R. Moxon. 2000. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial. JAMA 283:2795-2801.
22. Martin, D., N. Cadieux, J. Hamel, and B. R. Brodeur. 1997. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J. Exp. Med. 185:1173-1183.
23. Martin, S. L., R. Borrow, P. van der Ley, M. Dawson, A. J. Fox, and K. A. V. Cartwright. 2000. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine. Vaccine 18:2476-2481.
24. Masignani, V., M. Comanducci, M. M. Giuliani, S. Bambini, J. Adu-Bobie, B. Aricò, B. Brunelli, A. Pieri, L. Santini, S. Savino, D. Serruto, D. Litt, S. Kroll, J. A. Welsch, D. M. Granoff, R. Rappuoli, and M. Pizza. 2003. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197:789-799.
25. McNeil, G., and M. Virji. 1997. Phenotypic variants of meningococci and their potential in phagocytic interactions: the influence of opacity proteins in pili, PilC and surface sialic acids. Microb. Pathog. 22:295-304.
26. Milagres, L. G., S. R. Ramos, C. T. Sacchi, C. E. A. Melles, V. S. D. Vieira, H. Sato, G. S. Brito, J. C. Moraes, and C. E. Frasch. 1994. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:4419-4424.
27. Moe, G. R., S. Tan, and D. M. Granoff. 1999. Differences in surface expression of NspA among Neisseria meningitidis group B strains. Infect. Immun. 67:5664-5675.
28. Mountzouros, K. T., and A. P. Howell. 2000. Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis. J. Clin. Microbiol. 38:2878-2884.
29. Parkhill, J., M. Achtman, K. C. James, S. D. Bentley, C. Churcher, S. R. Klee, G. Morelli, E. Basham, D. Brown, T. Chillingworth, R. M. Davies, P. Davis, K. Devlin, T. Feltwell, N. Hamlin, S. Holroyd, K. Jagels, S. Leather, S. Moule, K. Mungall, M. A. Quail, M.-A. Rajandream, K. M. Rutherford, M. Simmonds, J. Skelton, S. Whitehead, B. G. Spratt, and B. G. Barrell. 2000. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404:502-506.
30. Pizza, M., V. Scarlato, V. Masignani, M. M. Giuliana, B. Aricò, M. Comanducci, G. T. Jennings, L. Baldi, E. Bartolini, B. Capecchi, C. L. Galeotti, E. Luzzi, R. Manetti, E. Marchetti, M. Mora, S. Nuti, G. Ratti, L. Santini, S. Savino, M. Scarselli, E. Storni, P. Zuo, M. Broeker, E. Hundt, B. Knapp, E. Blair, T. Mason, H. Tettelin, D. W. Hood, A. C. Jeffries, N. J. Saunders, D. M. Granoff, J. C. Venter, E. R. Moxon, G. Grandi, and R. Rappuoli. 2000. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816-1820.
31. Poolman, J. T. 1995. Development of a meningococcal vaccine. Infect. Agents Dis. 4:13-28.
32. Ramsay, M. E., N. Andrews, E. B. Kaczmarski, and E. Miller. 2001. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357:195-196.
33. Sacchi, C. T., A. M. Whitney, T. Popovic, D. S. Beall, M. W. Reeves, B. D. Plikaytis, N. E. Rosenstein, B. A. Perkins, M. L. C. Tondella, and L. W. Mayer. 2000. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J. Infect. Dis. 182:1169-1176.
34. Salzberg, S. L., A. L. Delcher, S. Kasif, and O. White. 1998. Microbial gene identification using interpolated Markov models. Nucleic Acids Res. 26:544-548.
35. Seitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for constructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
36. Sierra, G. V. G., H. C. Campa, and N. W. Varcacel. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207.
37. Slot, J. W., and H. J. Geuze. 1984. Gold markers for single and double immunolabeling of ultrathin cryosections, p. 129. In J. M. Polak and I. M. Varndell (ed.), Immunolabeling for electron microscopy. Elsevier, Amsterdam, The Netherlands.
38. Sneath, P. H. A., and R. R. Sokal. 1973. Numerical taxonomy - the principles and practice of numerical taxonomy. Freeman Press, San Francisco, Calif.
39. Stephens, D. S., and S. M. Zimmer. 2002. Pathogenesis, therapy, and prevention of meningococcal sepsis. Curr. Infect. Dis. Rep. 4:377-386.
40. Tappero, J. W., R. Lagos, A. M. Ballesteros, B. Plikaytis, D. Williams, J. Dykes, L. L. Gheesling, G. M. Carlone, E. A. Hoiby, J. Holst, H. Nokleby, E. Rosenqvist, G. Sierra, C. Campa, F. Sotolongo, J. Vega, J. Garcia, P. Herrera, J. T. Poolman, and B. A. Perkins. 1999. Immunogenicity of 2 serogroup B outer membrane protein meningococcal vaccines. A randomized controlled trial in Chile. JAMA 281:1520-1527.
41. Tettelin, H., N. J. Saunders, J. Heidelberg, A. C. Jeffries, K. E. Nelson, J. A. Eisen, K. A. Ketchum, D. W. Hood, J. F. Peden, R. J. Dodson, W. C. Nelson, M. L. Gwinn, R. DeBoy, J. D. Peterson, E. K. Hickey, D. H. Haft, S. L. Salzberg, O. White, R. D. Fleischmann, B. A. Dougherty, T. Mason, A. Ciecko, D. S. Parksey, E. Blair, H. Cittone, E. B. Clark, M. D. Cotton, T. R. Utterback, H. Khouri, H. Qin, J. Vamathevan, J. Gill, V. Scarlato, V. Masignani, M. Pizza, G. Grandi, L. Sun, H. O. Smith, C. M. Fraser, E. R. Moxon, R. Rappuoli, and J. C. Venter. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809-1815.
42. Tondella, M. L. C., T. Popovic, N. E. Rosenstein, D. B. Lake, G. M. Carlone, L. W. Mayer, B. A. Perkins, and The Active Bacterial Core Surveilance Team. 2000. Distribution of Neisseria meningitidis serosubtypes and serotypes circulating in the United States. J. Clin. Microbiol. 38:3323-3328.
43. Wenger, J. D. 1999. Serogroup B meningococcal disease: new outbreaks, new strategies. JAMA 281:1541-1543.
44. Wu, H. C. 1996. Biosynthesis of lipoproteins, p. 1005-1014. In F. C. Neidhardt et al. (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C.
45. Zagursky, R. J., and D. Russell. 2003. Bioinformatics: use in bacterial vaccine discovery, p. 261-285. In S. M. Brown (ed.), BioComputing: computer tools for biologists. Eaton Publishing, Westborough, Mass.